‍

Rob Rodrigues, partner at Licks Attorneys, assisted the Intellectual Property Owners Association (IPO) with the draft of comments submitted in response to the “Joint USPTO–FDA Collaboration Initiatives”, sent by the to the US Patent and Trademark Office (USPTO). The text brings together comments on the collaboration initiatives between the two North American agencies (USPTO and FDA). Rob, Vice-Chair of the IPO Latin American Committee helped the draft to be able to include the international experience in Brazil when the local Drug Regulatory Agency (called Anvisa) participated in the patent examination process, as per revoked article 229-C. Read more at: https://ipo.org/wp-content/uploads/2023/02/USPTO-and-FDA-Collaboration-Comments.pdf

-

Roberto Rodrigues, sócio do Licks Attorneys, foi um dos envolvidos na preparacao do documento “Comments on Joint USPTO–FDA Collaboration Initiatives”, enviado pela Intellectual Property Owners Association (IPO) ao US Patent and Trademark Office (USPTO). O texto reúne comentários sobre as propostas de colaboração entre as duas agências norte-americanas (USPTO e FDA). Rob apresentou a experiência do Brasil ao envolver a agência de vigilância sanitária (Anvisa) no processo de concessão de patentes. Saiba mais em: https://ipo.org/wp-content/uploads/2023/02/USPTO-and-FDA-Collaboration-Comments.pdf

‍